Results 41 to 50 of about 2,389,723 (301)
Scientific Reports, 2022 Age-related macular degeneration (AMD) is a devastating retinal disease that results in irreversible vision loss in the aged population. The complex genetic nature and degree of genetic penetrance require a redefinition of the current therapeutic ...
Kaushal Sharma +4 more
doaj +1 more source
Frontiers in Medicine, 2022 PurposeTo compare the efficacies and treatment outcomes of intravitreal anti-VEGF agents and laser therapy in retinopathy of prematurity (ROP).MethodsA retrospective, non-randomized, comparative study of patients diagnosed with type 1 ROP or aggressive ...
Dandan Linghu +27 more
doaj +1 more source
Frontiers in Endocrinology, 2023 PurposeTo conduct a network meta-analysis (NMA) comparing the efficacy of anti-vascular endothelial growth factor (VEGF) therapy alone versus laser photocoagulation (LP) therapy alone or anti-VEGF therapy combined with LP therapy for diabetic macular ...
Jiasheng Chen +5 more
doaj +1 more source
Anti-VEGF Therapy and the Retina: An Update [PDF]
Journal of Ophthalmology, 2015 Ocular angiogenesis and macular oedema are major causes of sight loss across the world. Aberrant neovascularisation, which may arise secondary to numerous disease processes, can result in reduced vision as a result of oedema, haemorrhage, and scarring.
Tah, V +7 more
openaire +4 more sources
Predictive biomarkers of age-related macular degeneration response to anti-VEGF treatment [PDF]
, 2021 Age-related macular degeneration (AMD) is an incurable disease associated with aging that destroys sharp and central vision. Increasing evidence implicates both systemic and local inflammation in the pathogenesis of AMD.
Ochoa, Rodrigo +15 more
core +1 more source
Anti-Vascular Endothelial Growth Factor Antibody Suppresses ERK and NF-κB Activation in Ischemia-Reperfusion Lung Injury. [PDF]
PLoS ONE, 2016 Ischemia-reperfusion (IR)-induced acute lung injury (ALI) is implicated in several clinical conditions like lung transplantation, acute pulmonary embolism after thrombolytic therapy, re-expansion of collapsed lung from pneumothorax or pleural effusion ...
Chou-Chin Lan +5 more
doaj +1 more source
BMJ Open Ophthalmology, 2022 Purpose To evaluate the efficacy and safety of antivascular endothelial growth factor (anti-VEGF) agents in treating macular oedema due to retinal vein occlusion (RVO-ME).Methods Studies of randomised controlled trials were searched in PubMed, EMBASE ...
Chao Zhang +3 more
doaj +1 more source
Anti-VEGF-A antibody does not recognize VEGF-A : Incubation with VEGF-A antibody
, 2011 This antibody recognizes the VEGF-A monomer (22.5 kDa) and dimer (45 kDa) in control and glaucomatous retinas (first two lanes). VEGF-A antibody does not recognize 25 ng, 100 ng, or 250 ng of VEGF-A recombinant protein in the same membrane (last three ...
Wei Huang (36889) +5 more
core +1 more source
Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice
Biomedicines, 2023 Neovascular age-related macular degeneration (nAMD) with choroidal neovascularization (CNV) is a leading cause of blindness in the elderly in developed countries.
Chengchi Huang +6 more
doaj +1 more source
Predictive model for Age-Related Macular Degeneration Response to Anti-VEGF treatment [PDF]
, 2023 During the last years, signature-based predictive models have been applied to different pathologies obtaining promising results. Those models take special consideration in situations where there is not clear clinical guidelines to choose between ...
Ana Isabel Oca Lázaro +4 more
core